Your browser is no longer supported. Please, upgrade your browser.
TAK [NYSE]
Takeda Pharmaceutical Company Limited
Index- P/E10.87 EPS (ttm)1.32 Insider Own0.01% Shs Outstand3.14B Perf Week-0.49%
Market Cap44.89B Forward P/E3.73 EPS next Y3.83 Insider Trans0.00% Shs Float3.12B Perf Month4.23%
Income4.15B PEG18.73 EPS next Q- Inst Own3.00% Short Float0.25% Perf Quarter3.17%
Sales29.81B P/S1.51 EPS this Y745.90% Inst Trans-0.38% Short Ratio2.74 Perf Half Y-16.52%
Book/sh14.85 P/B0.96 EPS next Y- ROA3.80% Target Price17.87 Perf Year-18.52%
Cash/sh1.77 P/C8.08 EPS next 5Y0.58% ROE9.30% 52W Range13.17 - 19.97 Perf YTD4.92%
Dividend0.80 P/FCF8.33 EPS past 5Y- ROI5.30% 52W High-28.37% Beta0.90
Dividend %5.59% Quick Ratio0.90 Sales past 5Y- Gross Margin69.90% 52W Low8.58% ATR0.24
Employees47099 Current Ratio1.30 Sales Q/Q7.10% Oper. Margin18.80% RSI (14)53.07 Volatility2.19% 1.59%
OptionableYes Debt/Eq0.79 EPS Q/Q1038.60% Profit Margin13.90% Rel Volume1.53 Prev Close14.30
ShortableYes LT Debt/Eq0.75 EarningsOct 28 BMO Payout- Avg Volume2.88M Price14.30
Recom3.00 SMA200.91% SMA502.91% SMA200-9.11% Volume0 Change0.00%
Oct-07-21Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-19-21Downgrade JP Morgan Overweight → Neutral
Nov-01-19Initiated Cowen Market Perform $19.50
Aug-15-19Downgrade Daiwa Securities Outperform → Neutral
Jan-21-22 06:00PM  
Jan-19-22 07:00PM  
01:38PM  
09:38AM  
09:38AM  
Jan-18-22 01:38PM  
Jan-12-22 07:09PM  
Jan-10-22 04:30PM  
07:00AM  
Dec-22-21 08:11AM  
Dec-21-21 05:00PM  
09:01AM  
Dec-20-21 11:40AM  
Dec-17-21 11:08AM  
Dec-16-21 12:32PM  
05:46AM  
12:11AM  
Dec-13-21 08:00AM  
Dec-08-21 07:00AM  
Dec-07-21 08:00AM  
Dec-02-21 09:49AM  
Nov-30-21 09:30AM  
08:00AM  
Nov-25-21 09:08AM  
Nov-23-21 05:45PM  
05:24PM  
Nov-17-21 08:14AM  
Nov-16-21 07:53AM  
Nov-10-21 02:32PM  
02:10PM  
Nov-09-21 01:19PM  
12:14PM  
Nov-04-21 09:21AM  
Nov-01-21 06:30AM  
Oct-29-21 11:58AM  
08:07AM  
05:34AM  
Oct-28-21 06:30AM  
03:01AM  
02:46AM  
02:15AM  
Oct-27-21 01:16PM  
12:03PM  
09:15AM  
08:48AM  
01:18AM  
Oct-19-21 06:54AM  
06:51AM  
Oct-14-21 10:08AM  
Oct-13-21 08:00AM  
Oct-12-21 07:31AM  
Oct-07-21 10:07PM  
06:15PM  
Oct-06-21 04:59PM  
04:05PM  
03:54PM  
05:54AM  
Oct-05-21 07:33PM  
Oct-01-21 02:52AM  
Sep-30-21 07:43AM  
04:00AM  
Sep-24-21 01:16PM  
Sep-22-21 09:30AM  
08:55AM  
Sep-21-21 11:00AM  
08:00AM  
Sep-16-21 06:08AM  
Sep-15-21 05:42PM  
04:40PM  
Sep-13-21 08:51PM  
Sep-07-21 04:05PM  
10:45AM  
07:51AM  
05:54AM  
Sep-06-21 10:53PM  
Sep-03-21 10:10AM  
Sep-02-21 10:09AM  
Sep-01-21 04:31PM  
09:47AM  
08:10AM  
05:25AM  
02:25AM  
Aug-31-21 01:25PM  
11:17AM  
Aug-30-21 08:52AM  
03:08AM  
Aug-29-21 08:46PM  
08:34PM  
Aug-28-21 10:11PM  
04:29AM  
Aug-26-21 11:46AM  
07:51AM  
Aug-25-21 07:54PM  
Aug-19-21 10:23AM  
Aug-18-21 11:00AM  
Aug-10-21 03:54PM  
09:47AM  
Aug-05-21 07:00AM  
Aug-02-21 10:26AM  
Aug-01-21 09:10PM  
Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, and out-licensing of pharmaceutical products worldwide. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the Entyvio, Gattex/Revestive, Alofisel, Natpara, Adynovate/Adynovi, Takhzyro, Elaprase, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Albumin/Flexbumin, Ninlaro, and Alunbrig brands. Takeda Pharmaceutical Company has licensing agreements with Denali Therapeutics and Wave Life Sciences Ltd; collaboration agreements with Neurocrine Biosciences, Inc. and Rani Therapeutics LLC; license and research agreements with The University of Texas MD Anderson Cancer Center, Poseida Therapeutics, Inc., and Arrowhead Pharmaceuticals Inc.; research collaboration agreements with Arrowhead Pharmaceuticals Inc. and Ovid Therapeutics Inc.; and collaboration with Evox Therapeutics Ltd., as well as a licensing agreement with ProThera Biologics Inc. It also has strategic alliances with Egle Therapeutics SAS; Evotec SE; Neurocrine Biosciences, Inc.; Carmine Therapeutics; HemoShear Therapeutics, LLC; KSQ Therapeutics; and Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.